Kyowa Kirin Co., Ltd.;St. Marianna University School of Medicine
发明人:
申请号：
EP18761682.6
公开号：
EP3590535A1
申请日:
2018.03.02
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
An object of the present invention is to provide a novel therapeutic or preventive agent for human T cell leukemia virus type-1 associated myelopathy (HAM) containing an anti-human CC-chemokine receptor 4 (CCR4) antibody or an antibody fragment thereof as an active ingredient, and characterized by the administration and dosage of the antibody or the antibody fragment thereof. The present invention relates to a therapeutic or preventative agent for HAM characterized in that an anti-human CCR4 antibody or an antibody fragment thereof is contained as an active ingredient and the antibody or the antibody fragment thereof is administered at a low dose.
